These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18545659)

  • 1. Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.
    Polonelli L; Pontón J; Elguezabal N; Moragues MD; Casoli C; Pilotti E; Ronzi P; Dobroff AS; Rodrigues EG; Juliano MA; Maffei DL; Magliani W; Conti S; Travassos LR
    PLoS One; 2008 Jun; 3(6):e2371. PubMed ID: 18545659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies as crypts of antiinfective and antitumor peptides.
    Magliani W; Conti S; Cunha RL; Travassos LR; Polonelli L
    Curr Med Chem; 2009; 16(18):2305-23. PubMed ID: 19519392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.
    Gabrielli E; Pericolini E; Cenci E; Ortelli F; Magliani W; Ciociola T; Bistoni F; Conti S; Vecchiarelli A; Polonelli L
    PLoS One; 2009 Dec; 4(12):e8187. PubMed ID: 19997599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Actin-binding complementarity-determining region 2 of variable heavy chain from monoclonal antibody C7 induces apoptosis in several human tumor cells and is protective against metastatic melanoma.
    Arruda DC; Santos LC; Melo FM; Pereira FV; Figueiredo CR; Matsuo AL; Mortara RA; Juliano MA; Rodrigues EG; Dobroff AS; Polonelli L; Travassos LR
    J Biol Chem; 2012 Apr; 287(18):14912-22. PubMed ID: 22334655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activities of peptides corresponding to conserved complementary determining regions from different immunoglobulins.
    Figueiredo CR; Matsuo AL; Massaoka MH; Polonelli L; Travassos LR
    Peptides; 2014 Sep; 59():14-9. PubMed ID: 24972300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ig V
    Girola N; Matsuo AL; Figueiredo CR; Massaoka MH; Farias CF; Arruda DC; Azevedo RA; Monteiro HP; Resende-Lara PT; Cunha RL; Polonelli L; Travassos LR
    Peptides; 2016 Nov; 85():1-15. PubMed ID: 27575453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo.
    Figueiredo CR; Matsuo AL; Azevedo RA; Massaoka MH; Girola N; Polonelli L; Travassos LR
    Sci Rep; 2015 Sep; 5():14310. PubMed ID: 26391685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the Structure-Function Relationship of a Fungicidal Peptide Derived from the Constant Region of Human Immunoglobulins.
    Ciociola T; Pertinhez TA; Giovati L; Sperindè M; Magliani W; Ferrari E; Gatti R; D'Adda T; Spisni A; Conti S; Polonelli L
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2435-42. PubMed ID: 26856836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
    Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells.
    Dobroff AS; Rodrigues EG; Juliano MA; Friaça DM; Nakayasu ES; Almeida IC; Mortara RA; Jacysyn JF; Amarante-Mendes GP; Magliani W; Conti S; Polonelli L; Travassos LR
    Transl Oncol; 2010 Aug; 3(4):204-17. PubMed ID: 20689762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
    Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
    J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
    Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
    Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions.
    Sompuram SR; Den W; Sharon J
    J Immunol; 1996 Feb; 156(3):1071-81. PubMed ID: 8557981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
    De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
    J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Peptide based antifungal immunotherapy.
    Magliani W; Conti S; Giovati L; Zanello PP; Sperindè M; Ciociola T; Polonelli L
    Front Microbiol; 2012; 3():190. PubMed ID: 22675322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional consequences of complementarity-determining region deactivation in a multifunctional anti-nucleic acid antibody.
    Lee J; Kim HJ; Roh J; Seo Y; Kim M; Jun HR; Pham CD; Kwon MH
    J Biol Chem; 2013 Dec; 288(50):35877-85. PubMed ID: 24155236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A germline knowledge based computational approach for determining antibody complementarity determining regions.
    Zhao S; Lu J
    Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions.
    Maruthachalam BV; El-Sayed A; Liu J; Sutherland AR; Hill W; Alam MK; Pastushok L; Fonge H; Barreto K; Geyer CR
    Chembiochem; 2017 Nov; 18(22):2247-2259. PubMed ID: 28884521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered killer mimotopes: new synthetic peptides for antimicrobial therapy.
    Magliani W; Conti S; Salati A; Arseni S; Ravanetti L; Frazzi R; Polonelli L
    Curr Med Chem; 2004 Jul; 11(13):1793-800. PubMed ID: 15279582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.